Beyond matrix stiffness: targeting force-induced cancer drug resistance
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
During tumor progression, mechanical abnormalities in the tumor microenvironment (TME) trigger signaling pathways in cells that activate cellular programs, resulting in tumor growth and drug resistance. In this review, we describe mechanisms of action for anti-cancer therapies and mechanotransduction programs that regulate cellular processes, including cell proliferation, apoptosis, survival and phenotype switching. We discuss how the therapeutic response is impacted by the three main mechanical TME abnormalities: high extracellular matrix (ECM) composition and stiffness; interstitial fluid pressure (IFP); and elevated mechanical forces. We also review drugs that normalize these abnormalities or block mechanosensors and mechanotransduction pathways. Finally, we discuss current challenges and perspectives for the development of new strategies targeting mechanically induced drug resistance in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 2×
“In turn, this results in uniformly elevated IFP , washing drugs out of the tumor [12,13].”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 2×
“The dense ECM can also act as a physical barrier to immune cell infiltration, contributing to the formation of an immune-excluded phenotype [10,11].”
Background5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332 · cited 1×
“5-FU incorporates into DNA to inhibit DNA and RNA synthesis [19], whereas gemcitabine also induces DNA damage to prevent DNA replication [20].”
BackgroundAntiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589 · cited 1×
“Hypoxic environments can further fuel tumor progression via induction of the cancer stem cell (CSC) phenotype, epithelial-to-mesenchymal transition (EMT) , angiogenesis, inflammation, fibrosis, and immunosuppression [9].”
BackgroundHyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
The Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044 · cited 2×
“At the tissue level, the compressed and abnormal tumor blood vessels along with the increased deposition of matrix components in the tumor ECM, hinder the delivery of therapeutic agents to the tumor interior [83,84].”
BackgroundSelf-citationChauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031 · cited 1×
“It was shown that administering mechanotherapeutics, such as pirfenidone, losartan, tranilast, and dexamethasone, reduces tumor stiffness and mechanical forces, and increases tumor perfusion and drug delivery in preclinical tumor models of pancreatic and breast cancer [125,126,130–132].”
BackgroundSelf-citationEnvironment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892 · cited 1×
“…of integrin signaling, which results in overexpression of prosurvival and antiapoptotic proteins, cell cycle arrest, modulation of drug efflux, and a phenotype switching of cancer cells (e.g., EMT or cancer stemness), which is referred to as cell adhesion-mediated drug resistance (CAM-DR) [36].”
BackgroundGascoigne, K. E., & Taylor, S. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.002 · Cited by 832 · cited 1×
“Cancer cell sensitivity to certain chemotherapies (e.g., platinum based and taxanes) are cell cycle specific; thus, arrested cells may be less sensitive to the effects of chemotherapy [30,31].”
BackgroundMechanical compression drives cancer cells toward invasive phenotype
Tse, J. M., Cheng, G., Tyrrell, J. A., Wilcox-Adelman, S. A., Boucher, Y., Jain, R. K., & Munn, L. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118910109 · Cited by 631 · cited 1×
“These compressive mechanical cues have been linked with alterations in the proliferation rate, higher metastatic potential, and survival of cancer cells [4–8, 95, 96].”
BackgroundVan Cutsem, E., Tempero, M. A., Sigal, D., Oh, D.-Y., Fazio, N., Macarulla, T., Hitre, E., Hammel, P., Hendifar, A. E., Bates, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00590 · Cited by 499
Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.-R., Rehnmark, S., Verbeke, C., Toftgård, R., Löhr, M., & Heuchel, R. L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-95 · Cited by 394 · cited 1×
“Alterations in the expression of ABC drug transporter genes have also been observed in pancreatic [51] and hepatocellular carcinoma cells [52] grown on substrates of increased stiffness, which led to resistance to 5-FU, cisplatin, and paclitaxel.”
BackgroundStemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
Ip, C. K. M., Li, S.-S., Tang, M. Y. H., Sy, S. K. H., Ren, Y., Shum, H. C., & Wong, A. S. T. (2016) · Scientific Reports · doi:10.1038/srep26788 · Cited by 128
Mechanosensitive ion channels push cancer progression
Pethő, Z., Najder, K., Bulk, E., & Schwab, A. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.03.007 · Cited by 125 · cited 1×
“Ion channels are nonselective cation channels responding with channel gating to mechanical stress [137] or indirectly by integrins or other scaffolding elements, such as ECM components [94].”
BackgroundThe emerging role of ECM crosslinking in T cell mobility as a hallmark of immunosenescence in humans
Moreau, J.-F., Pradeu, T., Grignolio, A., Nardini, C., Castiglione, F., Tieri, P., Capri, M., Salvioli, S., Taupin, J.-L., Garagnani, P., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.005 · Cited by 67 · cited 1×
“Trafficking of T cells through dense collagen fibers can result in nuclear damage, impaired motility, and eventually cell death [78].”
BackgroundStover, E. H., Baco, M. B., Cohen, O., Li, Y. Y., Christie, E. L., Bagul, M., Goodale, A., Lee, Y., Pantel, S., Rees, M. G., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1243 · Cited by 49 · cited 1×
“Additionally, greater expression of antiapoptotic proteins BCL2L1 and MCL1 is associated with worse survival outcomes in patients with ovarian cancer [29].”
BackgroundSelf-citationLiu, M., Zhang, X., Long, C., Xu, H., Cheng, X., Chang, J., Zhang, C., Zhang, C., & Wang, X. (2018) · RSC Advances · doi:10.1039/c7ra13742g · Cited by 48 · cited 1×
“In line with this, ovarian tumor spheroids embedded in type I collagen-rich ECM showed increased invasive abilities and EMT, which subsequently led to chemoresistance, although the exact mechanism was unclear [55].”
BackgroundNovak, C. M., Horst, E. N., Lin, E., & Mehta, G. (2020) · Cancers · doi:10.3390/cancers12061521 · Cited by 47
Cited by
Extracellular matrix stiffness: Mechanisms in tumor progression and therapeutic potential in cancer
Zhang, M., & Zhang, B. (2025) · Experimental Hematology & Oncology · doi:10.1186/s40164-025-00647-2 · Cited by 269
“Finally, TGFβ is also essential for inducing CSC phenotype [70], and by inhibiting the TGF-β pathway and down-regulating Id1 and Id3 expression, CD44high and Id1high GIC groups are reduced, thereby reducing the tumorigenic ability of GICs (Fig.”
InfluentialUnraveling the Role of the Tumor Extracellular Matrix to Inform Nanoparticle Design for Nanomedicine
Cassani, M., Fernandes, S., Pagliari, S., Cavalieri, F., Caruso, F., & Forte, G. (2025) · Advanced Science · doi:10.1002/advs.202409898 · Cited by 48
Pan-cancer analyses suggest kindlin-associated global mechanochemical alterations
Chowdhury, D., Mistry, A., Maity, D., Bhatia, R., Priyadarshi, S., Wadan, S., Chakraborty, S., & Haldar, S. (2024) · Communications Biology · doi:10.1038/s42003-024-06044-5 · Cited by 5
Metadata
- Authors
- Kalli, M., Poskus, M. D., Stylianopoulos, T., & Zervantonakis, I. K.
- Venue
- Trends in Cancer
- Publisher
- Elsevier BV
- Published
- 2023-11
- Volume
- 9
- Issue
- 11
- Pages
- 937-954
- ISSN
- 2405-8025 (ISSN-L)
- 2405-8033
- OpenAlex
- W4385663638
- Cited by
- 167
- References
- 18
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.